CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM NEW
Total 13F shares
176,207
Share change
+8,595
Total reported value
$644,000
Price per share
$3.64
Number of holders
13
Value change
+$23,995
Number of buys
6
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q4 2015

As of 31 Dec 2015, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 176,207 shares. The largest 10 holders included VANGUARD GROUP INC, LADENBURG THALMANN FINANCIAL SERVICES INC, KCG Holdings, Inc., GEODE CAPITAL MANAGEMENT, LLC, Walleye Trading LLC, BlackRock Advisors LLC, ROYAL BANK OF CANADA, UBS Group AG, IFP Advisors, Inc, and WELLS FARGO & COMPANY/MN. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.